Povidone iodine

Generic Medicine Info
History of abnormal thyroid function or goitre (e.g. nodular colloid goitre, endemic goitre, Hashimoto's thyroiditis).
Special Precautions
Patient with serious wounds including burns. Renal impairment. Children. Pregnancy and lactation.
Adverse Reactions
Significant: Hypo- or hyper-thyroidism (long-term). Rarely, hypersensitivity reactions; conjunctival hyperaemia, superficial punctuate keratitis, cytotoxicity (ophth). Dermatologic: Rarely, local irritation, pruritus, rash, oedema, burns.
ROUTE(S) : Ophth / Vag: C
ROUTE(S) : Topical: D
Drug Interactions
May increase risk of thyroid-related reactions with lithium. Risk of formation of caustic compounds with ophthalmic formulations containing Hg-based preservatives.
CIMS Class
Acne Treatment Preparations / Mouth/Throat Preparations / Other Eye Preparations / Preparations for Vaginal Conditions / Psoriasis, Seborrhea & Ichthyosis Preparations / Skin Antiseptics & Disinfectants
ATC Classification
R02AA15 - povidone-iodine ; Belongs to the class of antiseptics used in throat preparations.
S01AX18 - povidone-iodine ; Belongs to the class of other antiinfectives. Used in the treatment of eye infections.
D11AC06 - povidone-iodine ; Belongs to the class of medicated shampoos.
D08AG02 - povidone-iodine ; Belongs to the class of iodine product antiseptics. Used in the treatment of dermatological diseases.
G01AX11 - povidone-iodine ; Belongs to the class of other antiinfectives and antiseptics. Used in the treatment of gynecological infections.
D09AA09 - povidone-iodine ; Belongs to the class of ointment dressings with antiinfectives.
Disclaimer: This information is independently developed by CIMS based on povidone iodine from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2022 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in